A mission-driven benefit organization advocating for evidence-based peptide access, translating science into policy, and certifying responsible suppliers.
The Peptide Access Alliance exists at the intersection of science, policy, and public health. We believe access to evidence-backed peptide therapeutics is a matter of wellness equity — and we're building the infrastructure to make that access safe, regulated, and broadly available.
We operate as a benefit LLC structured around three core pillars, each reinforcing the other in service of an evidence-driven, consumer-first mission.
The regulatory landscape for peptide therapeutics is fragmented and evolving. PAA works to shape that landscape through direct advocacy, coalition building, and regulatory comment — ensuring policies reflect the evidence, not fear.
We submit formal comments to regulatory agencies, connect with congressional offices, and build coalitions with practitioners, researchers, and patient advocates who share our vision.
The peptide market is unregulated in most jurisdictions. PAA's certification program sets the bar — independently assessing suppliers against a rigorous framework covering purity, labeling, manufacturing, and transparency.
Certification is structured in three tiers, each representing a higher level of compliance and transparency. Certified vendors are listed in the PAA public registry.
Whether you're building a better supply chain, conducting research, or advocating for access — PAA wants to hear from you. Tell us who you are and we'll follow up with relevant next steps.
Thank you for reaching out. We'll be in touch based on your role and interests. Welcome to the PAA.